Population-Based Cancer Survival in the Golestan Province in the Northeastern Part of Iran 2007–2012 Publisher Pubmed



Nemati S¹ ; Saeedi E¹ ; Roshandel G² ; Nahvijou A¹ ; Badakhshan A³ ; Akbari M⁴ ; Sedaghat SM³ ; Hasanpourheidari S² ; Hosseinpour R² ; Salamat F³ ; Lotfi F¹ ; Khosravi A⁵ ; Soerjomataram I⁶ ; Bray F⁶ Show All Authors Show Affiliations
Source: Cancer Epidemiology Published:2022

Abstract

Objective: We studied 5-year relative survival (RS) for 14 leading cancer sites in the population-based cancer registry (PBCR) of Golestan province in the northeastern part of Iran. Methodology: We followed patients diagnosed in 2007–2012 through data linkage with different databases, including the national causes of death registry and vital statistics office. We also followed the remaining patients through active contact. We used relative survival (RS) analysis to estimate 5-year age-standardized net survival for each cancer site. Multiple Imputation (MI) method was performed to obtain vital status for loss to follow-up (LTFU) cases. Results: We followed 6910 cancer patients from Golestan PBCR. However, 2162 patients were loss to follow-up. We found a higher RS in women (29.5%, 95% CI, 27.5, 31.7) than men (21.0%, 95% CI, 19.5, 22.5). The highest RS was observed for breast cancer in women (RS=49.8%, 95% CI, 42.2, 56.9) and colon cancer in men (RS=37.9%, 95% CI, 31.2, 44.6). Pancreatic cancer had the lowest RS both in men (RS= 8.7%, 95% CI, 4.1, 13.5) and women (RS= 7.9%, 95% CI, 5.0, 10.8) Conclusion: Although the 5-year cancer survival rates were relatively low in the Golestan province, there were distinct variations by cancer site. Further studies are required to evaluate the survival trends in Golestan province over time and compare them with the rates in the neighboring provinces and other countries in the region. © 2022